HC Wainwright Estimates Core Scientific Q1 Earnings

Core Scientific, Inc. (NASDAQ:CORZ) – Stock analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for Core Scientific in a note issued to investors on Tuesday, March 3rd. HC Wainwright analyst K. Dede expects that the company will earn $0.07 per share for the quarter. HC Wainwright has a “Buy” rating and a $25.00 price objective on the stock. The consensus estimate for Core Scientific’s current full-year earnings is $0.52 per share. HC Wainwright also issued estimates for Core Scientific’s Q2 2026 earnings at $0.09 EPS, Q3 2026 earnings at $0.09 EPS, Q4 2026 earnings at $0.09 EPS and FY2026 earnings at $0.33 EPS.

Core Scientific (NASDAQ:CORZ) last issued its quarterly earnings data on Monday, March 2nd. The company reported $0.42 EPS for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.69. The business had revenue of $79.76 million during the quarter, compared to analyst estimates of $118.45 million. During the same period in the previous year, the company posted ($0.69) earnings per share. Core Scientific’s revenue was down 16.0% on a year-over-year basis.

CORZ has been the topic of several other research reports. Needham & Company LLC raised shares of Core Scientific from a “hold” rating to a “buy” rating and set a $23.00 price objective on the stock in a research note on Tuesday. LADENBURG THALM/SH SH lowered their price target on Core Scientific from $24.50 to $23.75 and set a “buy” rating for the company in a report on Tuesday. Cantor Fitzgerald cut their price objective on shares of Core Scientific from $26.00 to $25.00 and set an “overweight” rating on the stock in a report on Tuesday. Weiss Ratings restated a “sell (d-)” rating on shares of Core Scientific in a report on Wednesday, January 21st. Finally, Citizens Jmp raised shares of Core Scientific from a “market perform” rating to an “outperform” rating and set a $30.00 price target on the stock in a research note on Thursday, December 18th. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $24.84.

Core Scientific Stock Up 3.5%

CORZ opened at $15.84 on Thursday. The firm has a market cap of $4.99 billion, a P/E ratio of 13.54 and a beta of 6.87. The business’s fifty day simple moving average is $17.28 and its 200 day simple moving average is $16.96. Core Scientific has a 52 week low of $6.20 and a 52 week high of $23.63.

Institutional Investors Weigh In On Core Scientific

A number of hedge funds have recently bought and sold shares of CORZ. Xponance LLC raised its position in shares of Core Scientific by 2.5% in the 4th quarter. Xponance LLC now owns 22,896 shares of the company’s stock valued at $333,000 after purchasing an additional 562 shares in the last quarter. Xponance Inc. grew its holdings in Core Scientific by 2.7% during the 3rd quarter. Xponance Inc. now owns 22,334 shares of the company’s stock worth $401,000 after acquiring an additional 595 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Core Scientific by 3.5% in the 3rd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 21,029 shares of the company’s stock worth $377,000 after purchasing an additional 711 shares during the last quarter. CWA Asset Management Group LLC raised its stake in shares of Core Scientific by 0.3% in the 4th quarter. CWA Asset Management Group LLC now owns 239,937 shares of the company’s stock valued at $3,493,000 after purchasing an additional 756 shares in the last quarter. Finally, Orion Porfolio Solutions LLC grew its stake in Core Scientific by 5.2% in the third quarter. Orion Porfolio Solutions LLC now owns 15,539 shares of the company’s stock worth $279,000 after purchasing an additional 766 shares in the last quarter.

Key Core Scientific News

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Analyst upgrade — Needham & Company upgraded CORZ from Hold to Buy with a $23 price target, signaling institutional support for the company’s AI pivot. Needham Upgrade
• Positive Sentiment: Buy ratings reaffirmed — HC Wainwright reiterated its Buy rating (with a $25 PT) and Canaccord raised its target to $20 (upgrade to Buy), adding momentum from multiple brokers. HC Wainwright Reiterate Canaccord Raise
• Positive Sentiment: Commercial traction — CoreWeave colocation deal is reportedly ahead of schedule, supporting faster-than-expected ramp in AI colocation revenue. CoreWeave Ahead
• Positive Sentiment: Unusually large call buying — Traders purchased a very large volume of call options (188,642 contracts), which can amplify upside moves and indicates bullish, short‑term positioning.
• Neutral Sentiment: Long‑term AI thesis — MarketBeat published a bullish thesis that Core Scientific’s $10B+ AI backlog and colocation growth could justify large multi‑year upside, but this is a long‑horizon view. MarketBeat AI Thesis
• Neutral Sentiment: Short‑interest data unreliable — Reports flag a large reported increase, but the published figures are zero/NaN and inconsistent; treat these short‑interest metrics with caution.
• Negative Sentiment: Q4/2025 results missed on revenue — Revenue fell sharply (reports say ~38% YoY decline) as BTC mining revenue slid during the AI transition, raising near‑term growth and margin questions. Q4 Revenue Miss
• Negative Sentiment: Share price reacted — The pivot and earnings swing prompted sharp intraday selling in some headlines (reports of a ~14% drop on the news), reflecting investor concern about near‑term profitability and execution risk. Stock Slide After Pivot
• Negative Sentiment: Mixed analyst moves — Ladenburg trimmed expectations (lowered its price target slightly) and Cantor Fitzgerald cut its target modestly while staying overweight, highlighting differing views and some caution on near‑term visibility. Ladenburg Lowered Expectations Cantor Fitzgerald Cut

Core Scientific Company Profile

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.